These medications, including semaglutide and liraglutide, reduce appetite and slow gastric emptying, leading to decreased caloric intake and subsequent weight reduction in patients with obesity or overweight conditions with metabolic complications
9.Tian G, Sawashita J, Kubo H, Nishio SY, Hashimoto S, Suzuki N, Yoshimura H, Tsuruoka M, Wang Y, Liu Y, Luo H, Xu Z, Mori M, Kitano M, Hosoe K, Takeda T, Usami S, Higuchi K
It drives energy expenditure, accelerates fat metabolism in the liver, and appears to produce meaningfully greater weight loss than dual-agonist approaches
After at least 30 days on the 7 mg dose, it may be increased to 14 mg once daily if additional glycaemic control is needed
I.NeubigR
Interferon gamma/NADPH oxidase defense system in immunity and cancer